Laura MaggiVeronica SantarlasciManuela CaponeMaria Caterina RossiValentina QuerciAlessio MazzoniRolando CimazRaffaele De PalmaFrancesco LiottaEnrico MaggiSergio RomagnaniLorenzo CosmiFrancesco Annunziato
T helper17 ( T h17) lymphocytes represent a third arm of the CD 4 + T ‐cell effector responses, in addition to T h1 and T h2 cells. T h17 cells have been found to exhibit high plasticity because they rapidly shift into the T h1 phenotype in inflammatory sites. In humans, T h1 cells derived from T h17 cells express CD 161, whereas classic T h1 cells do not; these T h17‐derived T h1 cells have been termed nonclassic T h1 cells. In this study, we examined similarities and differences between classic and nonclassic human T h1 cells by assessing a panel of T ‐cell clones, as well as CD 161 + or CD 161 − CD 4 + T cells derived ex vivo from the circulation of healthy subjects or the synovial fluid of patients with juvenile idiopathic arthritis. The results show that nonclassic T h1 cells can be identified based on CD 161 expression, as well as the consistent expression of retinoic acid orphan receptor C , IL ‐17 receptor E , CCR 6, and IL ‐4‐induced gene 1, which are all virtually absent in classic T h1 cells. The possibility to distinguish these two‐cell subsets by using such a panel of markers may allow the opportunity to better establish the respective pathogenic roles of classic and nonclassic ( T h17 derived) T h1 cells in different chronic inflammatory disorders.
Richard A. O’ConnorHelen CambrookKatja HuettnerStephen M. Anderton
Wei WuSamuel ShiHans‐Gustaf LjunggrenAntonio La CavaLuc Van KaerFu‐Dong ShiR. Liu
Veronika NindlReinhard MaierDavid RateringRita de GiuliRoland ZüstVolker ThielElke ScandellaFranco Di PadovaManfred KöpfMarkus RudinThomas RülickeBurkhard Ludewig
Heather M. Grifka‐WalkStephen J. LalorBenjamin M. Segal
M.‐R. KimSung‐Wook HongEun Byul ChoiW. LeeY.‐S. KimSeong Gyu JeonMyoung Ho JangYong Song GhoY.‐K. KimY.‐K. KimY.‐K. Kim